Renal infarction during the use of rizatriptan and zolmitriptan: Two case reports

Clinical Toxicology

Volumn 44, Issue 2, 2006, Pages 177-180

  Fulton, Jessica ^a   Kahn, Jason ^b   Nelson, Lewis ^a   Hoffman, Robert ^a  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Renal infarction; Rizatriptan; Vasospasm

Indexed keywords

BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CONTRAST MEDIUM; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; HYDROCODONE; INDOMETACIN; PREDNISONE; RIZATRIPTAN; ZOLMITRIPTAN; OXAZOLIDINONE DERIVATIVE; SEROTONIN AGONIST; TRIAZOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ABDOMEN; ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLUSTER HEADACHE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTENSION; KIDNEY INFARCTION; MALE; MIGRAINE; NAUSEA; PELVIS; VOMITING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INFARCTION; KIDNEY; MIDDLE AGED; RADIOGRAPHY; VASCULARIZATION;

ADULT; CLUSTER HEADACHE; HUMANS; INFARCTION; KIDNEY; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; SEROTONIN AGONISTS; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES; TRYPTAMINES;

EID: 33645960952     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650500514574     Document Type: Article

References (25)

1. Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC. How efficacious are 5-HT1B/D receptor ligands: an answer from GTPγS studies with stable transfected C6-glial cell lines. Neuropharmacology 1997; 36(4-5):499-512.
2. Goadsby PJ, Hargreaves RJ. Mechanisms of action of serotonin 5-HT1B/1D agonists: insights into migraine pathophysiology using rizatriptan. Neurology 2000; 55(Suppl. 2):S8-14.
3. Dechant K, Clissold S. Sumatriptan: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1992; 43:776-798.
4. Deleu D, Hanssens Y. Current and emerging second generation triptans in acute migraine therapy: A comparative review. J Clin Pharmacol 2000; 40:687-700.
5. th ed. New York: McGraw-Hill, 1996:939-949.
6. Cavazos JE, Caress JB, Chilukuri VR, Devlin T, Gray L, Hurwitz BJ. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet 1994; 343:1105-1106.
7. Jayamaha JEL, Street MK. Fatal cerebellar infarct in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med 1995; 21:82-83.
8. Meschia JF, Malkoff MD, Biller J. Reversible segmental cerebral arterial vasospasm and cerebral infarction: Possible association with excessive use of sumatriptan and Midrin. Arch Neurol 1998; 55:712-714.
9. Main ML, Ramaswamy K, Andrews TC. Cardiac arrest and myocardial infarction immediately after sumatriptan injection. Ann Intern Med 1998; 128:874.
10. Mueller L, Gallagher M, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache 1996; 36:329-331.
11. Knudsen JF, Friedman B, Chen M, Goldwasser JE. Ischemic colitis and sumatriptan use. Arch Intern Med 1998; 158:1946-1948.
12. Vijayan N, Peacock JH. Spinal cord infarction during use of zolmitriptan: A case report. Headache 2000; 40:57-60.
13. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurons only after blood-brain barrier disruption. Br J Pharmacol 1993; 109:788-792.
14. Ferrari MD, Saxena PRS. Clinical effects and mechanism of action of sumatriptan in migraine. Clin Neurol Neurosurg 1992; 94(Supp 1):73-77.
15. Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, Lines C. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine: the rizatriptan 046 study group. Headache 1998; 38:737-747.
16. Dooley M, Faulds D. Rizatriptan: a review of its efficacy in the management of migraine. Drugs 1999; 58(4):699-723.
17. Domanovits H, Paulis M, Nikfardjam M, Meron G, Kurkoiyan I, Bankier A, Laggner AN. Acute renal infarction: Clinical characteristics of 17 patients. Medicine (Baltimore) 1999; 78:386-394.
18. Barbey F, Matthieu C, Nseir G, Burnier M, Teta D. A young man with renal colic. J Intern Med 2003; 254(6):605-8.
19. Saleem TM, Singh M, Murtaza M, Singh A, Kasubhai M, Gnanasekaran I. Renal infarction: a rare complication of cocaine abuse. Am J Emerg Med 2001; 19(6):528-9.
20. Van Doorn KJ, Van der Niepen P, Van Tussenbroeck, Verbeelen D. Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy. Nephrol Dial Transplant 2000; 15:1877-1879.
21. Bizzarri F, Mondillo S, Guerrini F. Spontaneous acute coronary dissection after cocaine abuse in a young woman. Can J Cardiol 2003; 19: 297-299.
22. Hsue PY, Salinas CL, Bolger AF, Benowitz NL, Waters DD. Acute aortic dissection related to crack cocaine. Circulation 2002; 105:1592-1595.
23. Palmiere C, Burkhardt S, Staub C. Thoracic aortic dissection associated with cocaine abuse. Forensic Sci Int 2004; 141:137-142.
24. Tadipatri S, van Heuven-Nolsen D, Feniuk W, Saxena PR. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Br J Pharmacol 1991; 104(4):887-894.
25. Watts SW, Thompson JM. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. J Pharmacol Exp Ther 2004; 309(1):165-172.